Harald Holte
0000-0001-9799-9428
Oslo Universitetssykehus
7 papers found
Refreshing results…
Low lymphocyte‐to‐monocyte ratio predicts poor outcome in high‐risk aggressive large B‐cell lymphoma
Molecular features encoded in the ctDNA reveal heterogeneity and predict outcome in high-risk aggressive B-cell lymphoma
Patients with high-risk DLBCL benefit from dose-dense immunochemotherapy combined with early systemic CNS prophylaxis
Mutational dynamics and immune evasion in diffuse large B-cell lymphoma explored in a relapse-enriched patient series
TIGIT and PD-1 Mark Intratumoral T Cells with Reduced Effector Function in B-cell Non-Hodgkin Lymphoma
Validation of theMCL35 gene expression proliferation assay in randomized trials of the European Mantle Cell Lymphoma Network
-
Missing publications? Search for publications with a matching author name.